Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

researcher sitting at microscope greeting colleague

In Australia and New Zealand our team of 500 people help improve the lives of millions living with a range of diseases across broad therapeutic areas including heart, metabolic, renal, kidney, lung and oncology. Our long-standing relationships and unique collaborations with patient advocacy groups, healthcare professionals and other stakeholders helps us deliver innovative medicines and healthcare solutions that contribute to a better world.

The lives of animals and humans are interconnected in deep and complex ways. That’s why we use the synergies between our Animal Health and Human Health businesses to enhance the health and wellbeing of both. As the leading provider of animal health products for companion animals, our innovations in animal vaccines, parasiticides, and therapeutics safeguard the health of livestock and the livelihood of farmers and communities across rural and regional Australia and New Zealand.

Being a family business means it’s all about family. And we consider our employees, patients, communities and business partners all to be part of that family. That’s why we are proud to be recognised as a TOP employer and a leader in inclusion and diversity. So, while we’re always looking for opportunities to grow, we put people at the heart of everything we do.